Gerard Platenburg has served as our Chief Innovation Officer since February 2014. Gerard is a co-founder of our company and also served as the sole member of our supervisory board between August 2012 and December 2013. Gerard has an extensive background in RNA modulation and orphan drug discovery and development and is in charge of our innovation unit. Gerard has more than twenty years of senior managerial experience, which he gained during his different operational and leadership roles in growing biotech companies. Prior to joining our company, Gerard worked at Isa Pharmaceuticals B.V. from June 2009 to January 2014. Gerard co-founded Prosensa Holding N.V., growing it to become a well-known RNA modulation clinical stage company, and held various positions between April 2002 and May 2009, including Chief Executive Officer and Chief Development Officer. Gerard also worked at Pharming B.V. from April 1990 to March 2002. He is a passionate and driven pioneer of early stage technologies. Gerard has a master’s degree in chemistry and molecular biology from Leiden University in 1987 and pursued PhD work at Leiden University.   

 RNA Modulation